InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by Farwell Wildon, Directeur Médical. Officer active across 1 company, notably Dyne Therapeutics, Inc.. In total, 5 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €48k. History available since 10 December 2021. The latest transaction was filed on 14 June 2022 (Disposition). Regulator: SEC (Form 4). All data is free.
Declarations5 total
668 shares@ US$4.950.0001% mcap6.2% of flowCommon StockSEC:0001209191-22-037145:0
640 shares@ US$8.730.0002% mcap9.9% of flowCommon StockSEC:0001209191-22-018533:0
5,617 shares@ US$8.560.0015% mcap84.0% of flowCommon StockSEC:0001209191-22-015901:0
22,307 shares0Common StockSEC:0001209191-21-069422
22,307 shares0Common StockSEC:0001209191-21-069422:0
5 of 5 declarations
About Farwell Wildon
Wildon Farwell is the Chief Medical Officer at Dyne Therapeutics, Inc. He oversees the company's medical and research activities. His expertise is essential for developing innovative therapeutic solutions.
